Skip to main content
XGN
NASDAQ Life Sciences

Exagen Registers $150M Shelf, Including $50M TD Securities ATM

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$5.26
Mkt Cap
$127.425M
52W Low
$2.59
52W High
$10.27
52W Position info
103% above low
Off High info
49% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

XGN has more than doubled off its 52-week low of $2.59.

Summary

Exagen registered a $150 million aggregate shelf and signed a sales agreement with TD Securities to sell up to $50 million of common stock through an at-the-market program. The shelf is large next to the company's roughly $127 million market cap, and the ATM alone could add meaningfully to the share count. This lands the same day as the Q3 report, which showed revenue up 7% to $18.4M but cash down to $28.1M alongside a $5.0M debt draw — the company is lining up equity capacity while burning cash. The stock closed at $5.26, below the $5.81 level referenced when the shelf was registered, so any sales at current prices would be more dilutive than that initial math implied. Watch for 424B prospectus supplements disclosing actual share sales under the ATM.

At the time of this announcement, XGN was trading at $5.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127.4M. The 52-week trading range was $2.59 to $10.27. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

XGN - Latest Insights

XGN
Nov 10, 2026, 9:33 AM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $5.83
Real-time Price: $4.81 info
Change: -$1.02 (-17%) info
Market Cap: $116.524M info
XGN
Nov 10, 2026, 9:01 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.55
Real-time Price: $4.81 info
Change: -$1.74 (-27%) info
Market Cap: $116.524M info
XGN
Nov 10, 2026, 7:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.59
Real-time Price: $4.81 info
Change: -$2.78 (-37%) info
Market Cap: $116.524M info
XGN
Aug 04, 2026, 9:15 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.66
Real-time Price: $4.81 info
Change: -$0.850 (-15%) info
Market Cap: $116.524M info
XGN
Aug 04, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.60
Real-time Price: $4.81 info
Change: -$0.790 (-14%) info
Market Cap: $116.524M info